Rochlin Kate bought INAB
May 9, 2026 · Form 4 insider transaction
Rochlin Kate bought 60,000 shares of IN8bio, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$0.00
Total value
N/A
InsiderRochlin Kate
RoleOfficer
CompanyIN8bio, Inc. (INAB)
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 9, 2026
Filing dateMay 12, 2026
Shares owned after60,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Twenty-five percent (25%) of the shares subject to the option shall vest on each of November 9, 2026, May 9, 2027, November 9, 2027 and May 9, 2028, subject to the Reporting Person continuing to provide service through each such date.